Parallel Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.6K | Buy |
+181
| New | +$1.6K | ﹤0.01% | 3067 |
|
|
2025
Q1 | – | Sell |
-128
| Closed | -$1.35K | – | 3505 |
|
|
2024
Q4 | $1.35K | Buy |
128
+86
| +205% | +$904 | ﹤0.01% | 3036 |
|
|
2024
Q3 | $551 | Hold |
42
| – | – | ﹤0.01% | 3150 |
|
|
2024
Q2 | $591 | Hold |
42
| – | – | ﹤0.01% | 3055 |
|
|
2024
Q1 | $709 | Hold |
42
| – | – | ﹤0.01% | 2994 |
|
|
2023
Q4 | $593 | Hold |
42
| – | – | ﹤0.01% | 3033 |
|
|
2023
Q3 | $433 | Hold |
42
| – | – | ﹤0.01% | 3132 |
|
|
2023
Q2 | $692 | Hold |
42
| – | – | ﹤0.01% | 3027 |
|
|
2023
Q1 | $385 | Buy |
+42
| New | +$385 | ﹤0.01% | 3178 |
|
|
2021
Q3 | – | Sell |
-128
| Closed | -$1K | – | 3046 |
|
|
2021
Q2 | $1K | Buy |
+128
| New | +$1K | ﹤0.01% | 2664 |
|
|
2018
Q2 | – | Sell |
-697
| Closed | -$5K | – | 2085 |
|
|
2018
Q1 | $5K | Sell |
697
-264
| -27% | -$1.89K | ﹤0.01% | 1526 |
|
|
2017
Q4 | $8K | Buy |
+961
| New | +$8K | ﹤0.01% | 1367 |
|